Serial Number | 98125294 |
Word Mark | PHARMALYTICA |
Filing Date | Wednesday, August 9, 2023 |
Status | 653 - SUSPENSION LETTER - MAILED |
Status Date | Thursday, July 31, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Software as a service (SaaS) services featuring software in the fields of healthcare, and pharmacy services, namely, software as a service (SaaS) services featuring software for collecting, organizing, tracking, and analyzing pharmaceutical prescription and dispensation information and pharmacy clinical service information, software as a service (SaaS) services featuring software for accessing, querying and analyzing pharmacy prescription, dispensation, and clinical service information stored in databases and data warehouses, software as a service (SaaS) services featuring software to design and monitor medication treatment plans, track patient services, medication utilization, medication care gaps, medication adherence, and treatment outcomes of prescription medication, software as a service (SaaS) services featuring software for analyzing and optimizing medication treatment plans and monitoring medication utilization, medication care gaps, and medication adherence for chronic conditions, software as a service (SaaS) services featuring software for analyzing patient medications to improve patient safety and reduce medication-related risks, software as a service (SaaS) services featuring software for analyzing prescription, dispensation, and inventory flows of controlled medications for risk management and regulatory compliance purposes, software as a service (SaaS) services featuring software to optimize pharmacy clinical services and patient care through analysis of clinical service, prescription and dispensation information, and the generation of reports to support care planning, software as a service (SaaS) services featuring software to optimize clinical care and workflows through integration with pharmacy information systems; Providing temporary use of on-line non-downloadable web application software in the fields of healthcare and pharmacy services, namely, providing temporary use of on-line non-downloadable web application software for collecting, organizing, tracking, and analyzing pharmaceutical prescription and dispensation information, and pharmacy clinical service information; Providing temporary use of on-line non-downloadable web application software for accessing, querying and analyzing pharmacy prescription, dispensation, and clinical service information stored in databases and data warehouses; Providing temporary use of on-line non-downloadable web application software to design and monitor medication treatment plans, track patient services, medication utilization, medication care gaps, medication adherence, and treatment outcomes of prescription medication; Providing temporary use of on-line non-downloadable web application software for analyzing and optimizing medication treatment plans and monitoring medication utilization, medication care gaps, and medication adherence for chronic conditions; Providing temporary use of on-line non-downloadable web application software for analyzing patient medications to improve patient safety and reduce medication-related risks; Providing temporary use of on-line non-downloadable web application software for analyzing prescription, dispensation, and inventory flows of controlled medications for risk management and regulatory compliance; Providing temporary use of on-line non-downloadable web application software to optimize pharmacy clinical services and patient care through analysis of clinical service, prescription and dispensation information, and the generation of reports to support care planning; Providing temporary use of on-line non-downloadable web application software to optimize clinical care and workflows through integration with pharmacy information systems |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, September 10, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | PHARMALYTICA INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 99 - Other |
Address | CALGARY, ALBERTA T3A5C4 CA |
Party Name | Okaki Health Intelligence Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Calgary, Alberta T3A5C4 CA |
Event Date | Event Description |
Saturday, August 12, 2023 | NEW APPLICATION ENTERED |
Sunday, September 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, January 10, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Wednesday, April 17, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, April 9, 2024 | ASSIGNED TO EXAMINER |
Wednesday, April 17, 2024 | NON-FINAL ACTION WRITTEN |
Friday, May 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, May 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, June 21, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, June 21, 2024 | SUSPENSION LETTER WRITTEN |
Sunday, November 17, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Sunday, November 17, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, May 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, June 21, 2024 | LETTER OF SUSPENSION E-MAILED |
Wednesday, April 23, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Sunday, November 17, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, February 6, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Wednesday, April 23, 2025 | SUSPENSION INQUIRY WRITTEN |
Wednesday, April 23, 2025 | INQUIRY TO SUSPENSION E-MAILED |
Tuesday, July 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, July 22, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Thursday, July 31, 2025 | ASSIGNED TO LIE |
Thursday, July 31, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, July 31, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, July 31, 2025 | SUSPENSION LETTER WRITTEN |
Thursday, July 31, 2025 | LETTER OF SUSPENSION E-MAILED |
Thursday, July 31, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |